Please Wait.....
Report
CRISPR Technology: Global Markets
Market Research Report I 2024-10-23 I 122 Pages I BCC Research
Description
Report Scope
This report on CRISPR technology provides market projections for 2029 and analyzes the market for CRISPR technology by application and end user. Applications covered include drug development, agriculture, diagnostics and others. End users include biotechnology and pharmaceutical companies, academics and government research institutes, and contract research organizations.
Report Includes
- 32 data tables and 61 additional tables
- An analysis of the global market for CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology
- Analyses of the global market trends, with data from 2021-2022, estimates for 2023, forecast for 2024, and projected CAGRs through 2029
- Discussion of the market potential for CRISPR technology
- Estimate of the market size and a revenue forecast for the global CRISPR technology market, and a corresponding market share analysis by application, end user, and region
- Discussion of the major market dynamics, regulations, industry challenges, and macroeconomic factors that will affect the demand for CRISPR technology market over the next five years
- A look at the recent breakthrough in CRISPR-Cas9 genome editing technology, and how it has propelled the rapid growth in genetic engineering and advanced pharmacological research
- A comparative study on CRISPR with TALE and ZFN nuclease as a gene editing tool and discussion on its higher adaptability over other nucleases
- Review of the patent filings and research publications for innovations in the CRISPR-Cas9 genome editing technology
- A discussion on ESG challenges and ESG practices of the industry participants
- A look at the proprietary technologies and strategic alliances of the companies best positioned in the CRISPR market
- Analysis of the industry structure, competitive landscape, clinical trials, ongoing research activities, and the impact of COVID-19
- Company profiles of the major players, including Merck KGaA, Thermo Fisher Scientific, Beam Therapeutics, CRISPR Therapeutics and Danaher Corp.
Executive Summary
Summary:
This report on CRISPR technology provides market projections for 2029 and analyzes the market for CRISPR technology by application and end user. Applications covered include drug development, agriculture, diagnostics and others. End users include biotechnology and pharmaceutical companies, academics and government research institutes, and contract research organizations.
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Genome Editing
CRISPR
Introduction
Components of CRISPR
Mechanism of Action
CRISPR Gene Editing Workflow
Advantages and Disadvantages of CRISPR Technology
Pricing Analysis
PESTLE Analysis
Porter's Five Forces Analysis
Regulatory Landscape, by Type
Human
Gene Drives
Agriculture
Animals
Regulatory Landscape, by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 3 Market Dynamics
Market Dynamics Snapshot
Market Drivers
Rising Incidence of Chronic Diseases
Prevalence of Genetic Disorders
Government and Private Funding
Market Restraints
Alternative Technologies
Market Opportunities
Increase in the Number of Applications
Market Challenges
Complex and Evolving Regulatory Landscape
High Cost of CRISPR-based Therapy
Chapter 4 Emerging Technologies and Developments
Emerging Technologies
In Vivo Delivery of CRISPR
Improved Cas Variants
Artificial Intelligence
Clinical Trials Analysis
Clinical Trials Analysis, by Type of Study
Clinical Trials Analysis, by Status
Clinical Trials Analysis, by Phase
Clinical Trials
Patent Analysis
Patents, by Year
Patents, by Top Applicant
Patents, by Top Owner
Patents, by Jurisdiction
Intellectual Property Disputes and Patent Issues
Chapter 5 Market Segmentation Analysis
Segmentation Breakdown
Market Breakdown, by Application
Drug Development
Agriculture
Diagnostics
Other Applications
Market Breakdown, by End User
Biotech and Pharmaceutical Companies
Academics and Government Research Institutes
Contract Research Organizations
Geographic Breakdown
Market Analysis, by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 6 Competitive Intelligence
Market Analysis
Strategic Analysis
Chapter 7 Sustainability in CRISPR Technology: An ESG Perspective
Introduction to ESG
Sustainability in CRISPR Technology: An ESG Perspective
Key ESG Issues
CRISPR Technology ESG Performance Analysis
Environmental Performance
Social Performance
Governance Performance
Concluding Remarks from BCC
Chapter 8 Appendix
Methodology
References
Abbreviations
Company Profiles
AGILENT TECHNOLOGIES INC.
BEAM THERAPEUTICS
CARIBOU BIOSCIENCES INC.
CRISPR THERAPEUTICS
DANAHER CORP.
EDITAS MEDICINE
GENSCRIPT
INTELLIA THERAPEUTICS INC.
LONZA
MERCK KGAA
THERMO FISHER SCIENTIFIC INC.
List of Tables
Summary Table : Global Market for CRISPR Technology, by Application, Through 2029
Table 1 : Comparison of Genome Editing Techniques
Table 2 : Comparison of sgRNA Formats
Table 3 : Comparison of Cas Enzymes
Table 4 : Pricing Analysis of CRISPR Technology Products, by Company
Table 5 : Regulatory Rating: Human Gene Editing, by Country/Region
Table 6 : Regulatory Rating: Gene Drives, by Country/Region
Table 7 : Regulatory Rating: Crops/Food, by Country/Region
Table 8 : Regulatory Rating: Animals, by Country/Region
Table 9 : Regulatory Landscape in Asia-Pacific Countries
Table 10 : Regulatory Landscape in South American Countries
Table 11 : Chronic Diseases: Applications of CRISPR-based Therapy
Table 12 : Genetic Disease: CRISPR-based Therapy
Table 13 : CRISPR Technology: Venture Funding, 2021-2024
Table 14 : Clinical Trials in CRISPR Technology, by Type of Study, August 2024
Table 15 : Clinical Trials in CRISPR Technology, by Status, August 2024
Table 16 : Clinical Trials in CRISPR Technology, by Phase, August 2024
Table 17 : Select Clinical Trials, 2024
Table 18 : Patents Granted on CRISPR Technology, by Top Applicant, 2020-2023
Table 19 : Patents Granted on CRISPR Technology, by Top Owner, 2020-2023
Table 20 : Patents Granted on CRISPR Technology, by Jurisdiction, 2020-2023
Table 21 : Global Market for CRISPR Technology, by Application, Through 2029
Table 22 : CRISPR-Based Genetic Therapy: Pipeline, 2024
Table 23 : Global Market for Drug Development in CRISPR Technology, by Region, Through 2029
Table 24 : CRISPR-Edited Crops
Table 25 : Global Market for Agriculture in CRISPR Technology, by Region, Through 2029
Table 26 : CRISPR-based Diagnostics
Table 27 : Global Market for Diagnostics in CRISPR Technology, by Region, Through 2029
Table 28 : Global Market for Other Applications in CRISPR Technology, by Region, Through 2029
Table 29 : Global Market for CRISPR Technology, by End User, Through 2029
Table 30 : Biotech and Pharmaceutical Partners of CRISPR Technology Companies
Table 31 : Recent Collaborations Among Biotech, Pharma and CRISPR Technology Firms, 2023-2024
Table 32 : Global Market for Biotech and Pharma Companies for CRISPR Technology, by Region, Through 2029
Table 33 : Global Market for Academics and Government Research Institutes for CRISPR Technology, by Region, Through 2029
Table 34 : Global Market for CRO for CRISPR Technology, by Region, Through 2029
Table 35 : Global Market for CRISPR Technology, by Region, Through 2029
Table 36 : North American Market for CRISPR Technology, by Country, Through 2029
Table 37 : European Market for CRISPR Technology, by Country, Through 2029
Table 38 : Asia-Pacific Market for CRISPR Technology, by Country, Through 2029
Table 39 : Leading Companies in the CRISPR Technology Market
Table 40 : Small and Medium-Sized Companies in the CRISPR Technology Market
Table 41 : Recent Developments in the CRISPR Technology Market, 2022-2024
Table 42 : Bioethical Issues and Risks Associated with CRISPR Technology
Table 43 : ESG Rankings for CRISPR Technology Companies, 2024*
Table 44 : ESG: Environmental Overview
Table 45 : ESG: Social Overview
Table 46 : ESG: Governance Overview
Table 47 : Information Sources in this Report
Table 48 : Abbreviations Used in this Report
Table 49 : Agilent Technologies Inc.: Company Snapshot
Table 50 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 51 : Agilent Technologies Inc.: Product Portfolio
Table 52 : Agilent Technologies Inc.: News/Key Developments, 2021
Table 53 : Beam Therapeutics: Company Snapshot
Table 54 : Beam Therapeutics: Financial Performance, FY 2022 and 2023
Table 55 : Beam Therapeutics: Product Portfolio
Table 56 : Beam Therapeutics: News/Key Developments, 2021-2023
Table 57 : Caribou Biosciences Inc.: Company Snapshot
Table 58 : Caribou Biosciences Inc.: Financial Performance, FY 2022 and 2023
Table 59 : Caribou Biosciences Inc.: Product Portfolio
Table 60 : Caribou Biosciences Inc.: News/Key Developments, 2021-2023
Table 61 : CRISPR Therapeutics: Company Snapshot
Table 62 : CRISPR Therapeutics: Financial Performance, FY 2022 and 2023
Table 63 : CRISPR Therapeutics: Product Portfolio
Table 64 : CRISPR Therapeutics: News/Key Developments, 2022-2024
Table 65 : Danaher Corp.: Company Snapshot
Table 66 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 67 : Danaher Corp.: Product Portfolio
Table 68 : Danaher Corp.: News/Key Developments, 2021-2024
Table 69 : Editas Medicine: Company Snapshot
Table 70 : Editas Medicine: Financial Performance, FY 2022 and 2023
Table 71 : Editas Medicine: Product Portfolio
Table 72 : Editas Medicine: News/Key Developments, 2022 and 2023
Table 73 : GenScript: Company Snapshot
Table 74 : GenScript: Financial Performance, FY 2022 and 2023
Table 75 : GenScript: Product Portfolio
Table 76 : GenScript: News/Key Developments, 2021
Table 77 : Intellia Therapeutics Inc.: Company Snapshot
Table 78 : Intellia Therapeutics Inc.: Financial Performance, FY 2022 and 2023
Table 79 : Intellia Therapeutics Inc.: Product Portfolio
Table 80 : Intellia Therapeutics Inc.: News/Key Developments, 2021-2023
Table 81 : Lonza: Company Snapshot
Table 82 : Lonza Financial Performance, FY 2022 and 2023
Table 83 : Lonza: Product Portfolio
Table 84 : Lonza: News/Key Developments, 2022-2024
Table 85 : Merck KGaA: Company Snapshot
Table 86 : Merck KGaA: Financial Performance, FY 2022 and 2023
Table 87 : Merck KGaA: Product Portfolio
Table 88 : Merck KGaA: News/Key Developments, 2021
Table 89 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 90 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 91 : Thermo Fisher Scientific Inc: Product Portfolio
Table 92 : Thermo Fisher Scientific Inc.: News/Key Developments, 2021 and 2022
List of Figures
Summary Figure : Global Market for CRISPR Technology, by Application, 2021-2029
Figure 1 : CRISPR: Mechanism of Action
Figure 2 : CRISPR Gene Editing: Workflow
Figure 3 : Advantages and Disadvantages of CRISPR Technology
Figure 4 : PESTLE Analysis - CRISPR Technology
Figure 5 : Market Dynamics of CRISPR Technology
Figure 6 : Estimated Numbers of All Cancer Cases, Both Sexes, 2022-2050
Figure 7 : Global Estimates: People with Diabetes (20 to 79), 2021-2045
Figure 8 : Emerging Trends/Technologies in the CRISPR Technology Market
Figure 9 : Patents Granted on CRISPR Technology, by Year, 2020-2022
Figure 10 : Global Market Shares for CRISPR Technology, by Application, 2023
Figure 11 : CRISPR Technology in Drug Development
Figure 12 : Uses of CRISPR in Agriculture
Figure 13 : Global Market Shares for CRISPR Technology, by End User, 2023
Figure 14 : Number of Scientific Publications on CRISPR, by Year, 2020-2023
Figure 15 : Global Market Shares for CRISPR Technology, by Region, 2023
Figure 16 : North American Market Shares of CRISPR Technology, by Country, 2023
Figure 17 : U.S. Market for CRISPR Technology, 2021-2029
Figure 18 : Canadian Market for CRISPR Technology, 2021-2029
Figure 19 : European Market Shares of CRISPR Technology, by Country, 2023
Figure 20 : German Market for CRISPR Technology, 2021-2029
Figure 21 : U.K. Market for CRISPR Technology, 2021-2029
Figure 22 : French Market for CRISPR Technology, 2021-2029
Figure 23 : Rest of the European Market for CRISPR Technology, 2021-2029
Figure 24 : Asia-Pacific Market Shares of CRISPR Technology, by Country, 2023
Figure 25 : Chinese Market for CRISPR Technology, 2021-2029
Figure 26 : Japanese Market for CRISPR Technology, 2021-2029
Figure 27 : Indian Market for CRISPR Technology, 2021-2029
Figure 28 : Rest of Asia-Pacific Market for CRISPR Technology, 2021-2029
Figure 29 : RoW Market for CRISPR Technology, 2021-2029
Figure 30 : Pillars of ESG
Figure 31 : Advantages of ESG for Companies
Figure 32 : Methodology Used in the CRISPR Technology Market
Figure 33 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 34 : Agilent Technologies Inc.: Revenue Share, by Region, FY 2023
Figure 35 : Caribou Biosciences Inc.: Revenue Share, by Business Unit, FY 2023
Figure 36 : Caribou Biosciences Inc.: Revenue Share, by Country/Region, FY 2023
Figure 37 : Danaher Corp.: Market Share, by Business Unit, FY 2023
Figure 38 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 39 : GenScript: Revenue Share, by Business Unit, FY 2023
Figure 40 : GenScript: Revenue Share, by Country/Region, FY 2023
Figure 41 : Lonza: Revenue Share, by Business Unit, FY 2023
Figure 42 : Lonza: Revenue Share, by Country/Region, FY 2023
Figure 43 : Merck KGaA: Revenue Share, by Business Unit, FY 2023
Figure 44 : Merck KGaA: Revenue Share, by Region, FY 2023
Figure 45 : Thermo Fisher Scientific Inc.: Market Share, by Business Unit, FY 2023
Figure 46 : Thermo Fisher Scientific Inc.: Revenue Share, by Region, FY 2023
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security